Ovid Therapeutics Inc.
USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSY
Last updated:
Abstract:
Methods and compositions for treating narcolepsy are provided which include administering gaboxadol or a pharmaceutically acceptable salt thereof to a patient diagnosed with narcolepsy. Also provided are methods and compositions for treating narcolepsy which include administering to a patient in need thereof gaboxadol or a pharmaceutically acceptable salt thereof, in combination with one or more of a CNS stimulant, a eugeroic agent, an antidepressant or a GABA.sub.B receptor agonist.
Status:
Application
Type:
Utility
Filling date:
25 Mar 2020
Issue date:
16 Jul 2020